Straumann Holding AG provides tooth replacement solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic, and preventative dentistry. The company offers dental implant systems, including tissue and bone level implant lines; ceramic, mini, and dental implant systems; and guided surgery and surgical instruments, as well as implant-borne prosthetics, such as tissue and bone level prosthetics. It also provides biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. In addition, the company offers esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, 3D-soft tissue grafts, biologics, and other solutions; Roxolid for use in implant dentistry; SLActive implants; Endogain for wound healing; and short and bone level tapered implants. Further, it provides Neodent systems; Medentika solutions; Equinox dental implant systems; Clear Correct aligners; and training and education services to its customers. The company offers its products to general dentists, specialists, and dental technicians/laboratories, as well as corporate customers, such as dental chains, distributors, hospitals, and university clinics in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
Read More
